Digital Pathology and Whole-Slide Imaging
On this page
Direct answer
Whole-slide imaging digitises the entire glass slide: an automated scanner captures tiled images at 20x or 40x magnification (roughly 0.25 to 0.5 micrometres per pixel), stitches them into a single pyramidal file of several gigabytes, and serves it to a viewer that pans and zooms like a microscope. Digital pathology then adds the infrastructure — image management systems, laboratory information system integration, storage, and validation. The regulatory watershed came in 2017, when the United States cleared a whole-slide imaging system for primary diagnosis; since then clinical adoption has grown through remote reporting, second opinions, education and quantitative image analysis. Validation follows the College of American Pathologists guideline: at least sixty cases per intended application read in both modalities with documented concordance.
What you must remember
- Telepathology lineage: static image store-and-forward (older, selected fields only), dynamic robotic microscopy (real-time remote control of a motorised stage), and whole-slide imaging — the current standard replacing both.
- Validation rule: the CAP guideline recommends at least 60 cases for each intended application (for example, routine haematoxylin-eosin surgical pathology), read by each pathologist in both digital and glass modalities with concordance documented; major upgrades trigger revalidation.
- Magnification matters: 40x scanning preserves mitotic counting, microorganisms, cytological detail and dysplasia assessment; 20x suffices for many review tasks but is a compromise.
- Formats and interoperability: vendor formats and the DICOM whole-slide imaging standard, which lets images travel between systems the way radiology images do; compression is unavoidable but must be diagnostically lossless enough.
- Applications: primary diagnosis, intraoperative frozen sections by remote reporting, expert second opinions, education and proficiency testing, and the substrate on which artificial intelligence tools run.
- Limits: standard brightfield scanners do not capture fluorescence, so fluorescence in-situ hybridisation slides remain outside routine whole-slide workflows.
- Indian practice: telepathology links medical colleges and regional cancer centres; adoption is accelerating under national digital health initiatives, but each laboratory still validates locally within its accreditation scope.
Bringing a scanner into a working laboratory
The sequence matters more than the purchase. Slides are barcoded and loaded; the scanner finds tissue, selects focal planes and captures tiles, and a technician reviews scan quality — out-of-focus fields, tissue missed at the edges, air bubbles under the coverslip — before release. Files land in an image management system indexed to the laboratory information system, so a case opens as a digital slide beside its clinical data. Then validation: sixty or more consecutive representative cases covering the application's diagnostic spectrum, each reported from glass and from screen, discordances analysed and documented, and each sign-out pathologist repeating the exercise. After go-live, quality continues — periodic concordance audits, scan-failure logs, and retained glass slides as the legal archive. Laboratories that skip the validation file discover, at accreditation inspection, that the scanners were the easy part.
Where candidates slip
The numbers get confused: sixty cases per application, not sixty per pathologist per year, and each new application (immunohistochemistry, cytology) needs its own validation set because cytology and immunostains are harder to digitise diagnostically than routine histology. The second slip is assuming digital equals telepathology — whole-slide imaging is the technology; telepathology is one use of it. The third is forgetting physics: thick sections, darkly stained slides and heavily pigmented or calcified tissue scan poorly, so a digital workflow inherits every pre-analytical sin of the laboratory. A viva favourite asks why fluorescence in-situ hybridisation cannot simply be scanned — standard whole-slide scanners illuminate in brightfield; fluorescence capture requires different hardware outside most clinical deployments.
Frequently asked questions
How many cases does CAP guidance require for whole-slide imaging validation?
At least 60 cases per intended application, each read in both digital and glass-slide modalities with documented concordance.
Why is 40x scanning preferred for primary diagnosis?
Mitoses, microorganisms, nuclear detail and dysplasia grading need the resolution that 20x scanning sacrifices.
What are the three telepathology models?
Static image transfer, dynamic robotic microscopy, and whole-slide imaging-based virtual microscopy.
When was whole-slide imaging first cleared for primary diagnosis?
In 2017, by the United States regulator, moving the technology from research into routine clinical use.
Can fluorescence in-situ hybridisation be reported on whole-slide images?
Not on standard brightfield scanners — fluorescence capture requires dedicated hardware outside routine clinical workflows.